EUROPE’S LEADING VACCINE EVENT

 

 

What is World Vaccine Congress Europe?

The World Vaccine Congress Europe is the largest and most established European meeting on vaccine R&D

 

Conference

Covering Clinical Development, Bioprocessing & Manufacturing, Cancer Immunotherapy and much more
 

Exhibition

125+ leading solution providers from across the globe, featuring new ways of thinking and novel partnerships to generate solutions
 

APPLY TO SPONSOR/EXHIBIT

Networking

Networking is at the heart of World Vaccine Congress Europe. Our congress allows you to connect directly with thousands of vaccine experts across 4 days of built-in 1-2-1 networking  

REGISTER NOW

The Start-to-Finish of Vaccines

From clinical development & immune profiling to vaccine safety and market access

 
Vaccine Clinical Trials
Clinical Trials
Understand how to move your vaccine candidates through development phases to licensure
Covid & Beyond
Covid & Beyond
Pandemic preparedness, next generation vaccines, broadly protective and combination approaches
Cancer Immunotherapy
Cancer & Immunotherapy
Cancer vaccines and the future of combination treatments
Immune Profiling
Immune Profiling
Cancer vaccines and the future of combination treatments
Supply & Logistics
Supply & Logistics
Learn how we are dealing with the supply demands and the technologies that will allow last mile delivery
Market Access
Market Access
Understand the dynamics governing global vaccine markets & what interventions can be made for better access
Influenza & Respiratory
Influenza & Respiratory
Latest updates in RSV, influenza, pneumococcal, pan- and combinational vaccines
Vaccine Safety
Vaccine Safety
New tools to measure vaccine surveillance, safety and managing misinformation
Veterinary Vaccine
Veterinary
A one health approach to battle emerging zoonotic diseases and climate change
Bioprocessing & manufacturing
Bioprocessing & Manufacturing
Meet with the manufacturers & bioprocessing experts to advance your vaccine formulation, tech transfer & scale-up
Vaccine Partnerships
Partnerships
Secure funding and navigate through successful Public-Private-Partnerships with all stakeholders
Emerging and re-emerging diseases
Emerging & Re-Emerging Diseases
From Disease X preparedness, neglected diseases to global health vaccine development & new platforms

 

2024 Speakers

 

  • Jeffrey Almond at World Vaccine Congress Europe 2024
    Jeffrey Almond
    Former VP Discovery R&D, Sanofi & Visiting Professor
    University of Oxford - Oxford Vaccine Group
    Francesco Berlanda Scorza at World Vaccine Congress Europe 2024
    Francesco Berlanda Scorza
    Director GVGH
    GSK Vaccines for Global Health (GVGH)
  • Cedric Bogaert at World Vaccine Congress Europe 2024
    Cedric Bogaert
    Chief Executive Officer
    MYNEO NV
    Miles Carroll at World Vaccine Congress Europe 2024
    Miles Carroll
    Head of High Consequence Emerging Viruses Group, Pandemic Sciences Institute
    University of Oxford
  • Andrew Catchpole at World Vaccine Congress Europe 2024
    Andrew Catchpole
    CSO
    hVIVO
    Roman Chicz at World Vaccine Congress Europe 2024
    Roman Chicz
    Global Head Of External Research And Development
    Sanofi
  • Jakob Cramer at World Vaccine Congress Europe 2024
    Jakob Cramer
    Head Of Clinical Development
    CEPI
    Mark Emalfarb at World Vaccine Congress Europe 2024
    Mark Emalfarb
    Chief Executive Officer
    Dyadic International Inc
  • Marion Gruber at World Vaccine Congress Europe 2024
    Marion Gruber
    Vice President of Public Health and Regulatory Affairs
    IAVI
    Bassam Hallis at World Vaccine Congress Europe 2024
    Bassam Hallis
    Deputy Director, Research and Evaluation
    UK Health Security Agency
  • Ali M Harandi at World Vaccine Congress Europe 2024
    Ali M Harandi
    Lab Head, Dpt Of Microbiology And Immunology
    University of Gothenburg
    Mateusz Hasso-Agopsowicz at World Vaccine Congress Europe 2024
    Mateusz Hasso-Agopsowicz
    Technical Officer
    World Health Organization
  • Hans Keirstead at World Vaccine Congress Europe 2024
    Hans Keirstead
    Chief Executive Officer
    AIVITA Biomedical, Inc.
    Jerome Kim at World Vaccine Congress Europe 2024
    Jerome Kim
    Director General
    IVI
  • Zoltán Kis at World Vaccine Congress Europe 2024
    Zoltán Kis
    Lecturer
    Department of Chemical and Biological Engineering, The University of Sheffield
    Alexandre Le Vert at World Vaccine Congress Europe 2024
    Alexandre Le Vert
    Chief Executive Officer
    Osivax
  • Geert Leroux Roels at World Vaccine Congress Europe 2024
    Geert Leroux Roels
    Professor Emeritus
    Gent University
    Ab Osterhaus at World Vaccine Congress Europe 2024
    Ab Osterhaus
    Director of Research Center For Emerging Infections and Zoonoses and Professor
    University of Veterinary Medicine Hannover
  • Shanti Pather at World Vaccine Congress Europe 2024
    Shanti Pather
    Senior Global Medical Affairs Director, Vaccines
    BioNTech SE
    Jan Poolman at World Vaccine Congress Europe 2024
    Jan Poolman
    Head Bacterial Vaccine Discovery and Early Development
    Janssen
  • Ruben Rizzi at World Vaccine Congress Europe 2024
    Ruben Rizzi
    SVP Global Regulatory Affairs
    BioNTech SE
    Nigel Temperton at World Vaccine Congress Europe 2024
    Nigel Temperton
    Professor and Director
    University of Kent
  • Joris Vandeputte at World Vaccine Congress Europe 2024
    Joris Vandeputte
    President
    IABS
    Montserrat Arroyo at World Vaccine Congress Europe 2024
    Montserrat Arroyo
    Deputy Director General for International Standards and Science
    WOAH
  • Maria Elena Bottazzi at World Vaccine Congress Europe 2024
    Maria Elena Bottazzi
    Co-Director of Texas Children's Hospital Center for Vaccine Development
    Baylor College of Medicine
    Dennis Christensen at World Vaccine Congress Europe 2024
    Dennis Christensen
    Head of Global R&D
    Croda
  • Cyril Gay at World Vaccine Congress Europe 2024
    Cyril Gay
    Senior National Program Leader
    A.R.S. National Programs
    Edward Kelley at World Vaccine Congress Europe 2024
    Edward Kelley
    Chief Global Health Officer
    ApiJect
  • Ofer Levy at World Vaccine Congress Europe 2024
    Ofer Levy
    Director, Precision Vaccines Program
    Boston Children's Hospital
    Haiko Pillu at World Vaccine Congress Europe 2024
    Haiko Pillu
    Director Operations CPU
    SGS
  • Cesar Sanz Rodriguez at World Vaccine Congress Europe 2024
    Cesar Sanz Rodriguez
    Vice President, Medical Affairs - Europe, Middle East & Africa
    Moderna
    Helge Dorfmuller at World Vaccine Congress Europe 2024
    Helge Dorfmuller
    Principal Investigator
    University of Dundee
  • Jerald Sadoff at World Vaccine Congress Europe 2024
    Jerald Sadoff
    Chief Medical Officer
    Centivax
    Walter Straus at World Vaccine Congress Europe 2024
    Walter Straus
    Vice President, Clinical Safety & Risk Management
    Moderna Therapeutics

 

World Vaccine Congress Europe 2023 Testimonials
“Thank you very much to you and the rest of the Terrapinn team for organising the conference and making it a face to face meeting - which we find so vital.”

- CSO, hVIVO
World Vaccine Congress Europe 2023 Testimonials
“I had the pleasure of meeting and interacting with scientists, colleagues, collaborators and friends while enjoying talks and discussions on vaccines, infectious diseases and pandemic preparedness for the future.

- Head of Laboratory Science, CEPI
World Vaccine Congress Europe 2023 Testimonials
Thank you so much for all the work put in the World Vaccine Congress Europe, it was an excellent event. 

- Process Development Engineer & Digitalization Business Lead, APC Ltd.

Stay Up-to-Date

Join our mailing list to receive exclusive content and offers.

By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.

Explore the latest industry news from VaccineNation